- Pain Managements Drug
- NSAIDS
- Anesthetics
- Antidepressants
- Opioids
- Anesthetics
- Antihistamine Agents
- Others
- Pain Management Devices
- Neurostimulation devices
- Ablation Devices
- Analgesic Infusion Pumps
- Others
Pain Management Market size was valued at USD 38.8 billion in 2022 and is expected to reach USD 64.9 billion by 2028, at a significant CAGR of 7.6% from 2023-2029. Pain management caused by the intense damage of the tissue or any other illness. Pain may be the result of injury or different diseases such as diabetic neuropathy, arthritis, osteoarthritis, sclerosis, cancer, fibromyalgia or others. The management of the pain based on the severity and type of the pain. Pain can be classified into two types based on intensity, acute and chronic. Acute pain is sudden onset of the pain whre as chronic pain is persistent, usually due to ageing. There were many pain management solutions available in the market in form of drugs, devices and therapies. The global healthcare system has been influenced by the COVID-19 epidemic. The health officials are working to stop the spread of the coronavirus by enforcing lockdown rules, and most elective and non-urgent surgeries have been postponed around the world. As per the research article published in the Indian Journal of Anaesthesia 2020, COVID-19 has a negative impact on pain clinics, including interventional pain management procedures. The Indian Society of Anaesthesiologists also released recommendations on anaesthesia and intensive care techniques.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Huge number of factors such as advancements in the pain management techniques such as Neurostimulation devices, increase in ageing population, and established reimbursement scenario are projected to boost the market growth over the forecast period. In addition, high rates of trauma conditions, incidence of the chronic diseases such as arthritis, and cancer expected to bolster the market growth over the forecast period. However, low awareness among the patient pool regarding the availability of low invasive pain management techniques and alternative treatment methods are expected to hamper the market growth over the forecast period.
The key segments covered in the Pain Management Market are technology, components, application, and end-users.
The Pain Management Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
The Pain Management Market key players are Medtronic Plc (Ireland), DJO Global Inc. (U.S.), GlaxoSmithKline Plc (U.K.), Johnson and Johnson (U.S.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel)
1.Executive Summary |
2.Global Pain Management Market Introduction |
2.1.Global Pain Management Market - Taxonomy |
2.2.Global Pain Management Market - Definitions |
2.2.1.Type |
2.2.2.Condition |
2.2.3.Distribution Channel |
2.2.4.Seveority |
2.2.5.Region |
3.Global Pain Management Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Pain Management Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Pain Management Market By Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Pain Managements Drug |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Pain Management Devices |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Others |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Pain Management Market By Condition, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Cancer Pain |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Musculoskeletal Pain |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Neuropathic Pain |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Migraine & Facial Pain |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Others |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7.Global Pain Management Market By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Hospitals |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Clinics |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Others |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
8.Global Pain Management Market By Seveority, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Chronic Pain |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Acute Pain |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
9.Global Pain Management Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Pain Management Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Pain Managements Drug |
10.1.2.Pain Management Devices |
10.1.3.Others |
10.2. Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Cancer Pain |
10.2.2.Musculoskeletal Pain |
10.2.3.Neuropathic Pain |
10.2.4.Migraine & Facial Pain |
10.2.5.Others |
10.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Hospitals |
10.3.2.Clinics |
10.3.3.Others |
10.4. Seveority Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Chronic Pain |
10.4.2.Acute Pain |
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Pain Management Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Pain Managements Drug |
11.1.2.Pain Management Devices |
11.1.3.Others |
11.2. Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Cancer Pain |
11.2.2.Musculoskeletal Pain |
11.2.3.Neuropathic Pain |
11.2.4.Migraine & Facial Pain |
11.2.5.Others |
11.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Hospitals |
11.3.2.Clinics |
11.3.3.Others |
11.4. Seveority Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Chronic Pain |
11.4.2.Acute Pain |
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
11.5.6.Rest of EU |
12.Asia Pacific (APAC) Pain Management Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Pain Managements Drug |
12.1.2.Pain Management Devices |
12.1.3.Others |
12.2. Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Cancer Pain |
12.2.2.Musculoskeletal Pain |
12.2.3.Neuropathic Pain |
12.2.4.Migraine & Facial Pain |
12.2.5.Others |
12.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Hospitals |
12.3.2.Clinics |
12.3.3.Others |
12.4. Seveority Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Chronic Pain |
12.4.2.Acute Pain |
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Pain Management Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Pain Managements Drug |
13.1.2.Pain Management Devices |
13.1.3.Others |
13.2. Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Cancer Pain |
13.2.2.Musculoskeletal Pain |
13.2.3.Neuropathic Pain |
13.2.4.Migraine & Facial Pain |
13.2.5.Others |
13.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Hospitals |
13.3.2.Clinics |
13.3.3.Others |
13.4. Seveority Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Chronic Pain |
13.4.2.Acute Pain |
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Pain Management Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
14.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Pain Managements Drug |
14.1.2.Pain Management Devices |
14.1.3.Others |
14.2. Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.Cancer Pain |
14.2.2.Musculoskeletal Pain |
14.2.3.Neuropathic Pain |
14.2.4.Migraine & Facial Pain |
14.2.5.Others |
14.3. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Hospitals |
14.3.2.Clinics |
14.3.3.Others |
14.4. Seveority Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Chronic Pain |
14.4.2.Acute Pain |
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Medtronic Plc (Ireland) |
15.2.2.DJO Global Inc. (U.S.) |
15.2.3.GlaxoSmithKline Plc (U.K.) |
15.2.4.Johnson and Johnson (U.S.) |
15.2.5.Novartis AG (Switzerland) |
15.2.6.Pfizer Inc. (U.S.) |
15.2.7.Teva Pharmaceutical Industries Ltd. (Israel) |
16. Research Methodology |
17. Appendix and Abbreviations |